The Discounted Cash Flow (DCF) valuation of Bliss GVS Pharma Ltd (BLISSGVS.NS) is 170.74 INR. With the latest stock price at 317.55 INR, the upside of Bliss GVS Pharma Ltd based on DCF is -46.2%.
Based on the latest price of 317.55 INR and our DCF valuation, Bliss GVS Pharma Ltd (BLISSGVS.NS) is a sell. selling BLISSGVS.NS stocks now will result in a potential gain of 46.2%.
| Range | Selected | |
| WACC / Discount Rate | 13.6% - 16.1% | 14.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 147.11 - 206.66 | 170.74 |
| Upside | -53.7% - -34.9% | -46.2% |